why choose us

First received: August 28, 2023

Clinical Trial: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Leukemia

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine

Brief Summary: To compare an investigational oral form of the drug cladribine to the FDA approved form of the drug when it is given by vein (IV).

Read more